Using negative control outcomes to assess the comparability of treatment groups among postmenopausal women switching osteoporosis therapy
Publication
, Conference
McGrath, LJ; Kim, M; Pritchard, D; Yu, Y; Samai, P; Balasubramanian, A; Lin, J; Spangler, L; Stad, R; Bradbury, BD; Brookhart, MA
Published in: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
2021
Duke Scholars
Published In
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
EISSN
1099-1557
ISSN
1053-8569
Publication Date
2021
Volume
30
Start / End Page
389 / 390
Related Subject Headings
- Pharmacology & Pharmacy
- 4202 Epidemiology
- 3214 Pharmacology and pharmaceutical sciences
- 1117 Public Health and Health Services
- 1115 Pharmacology and Pharmaceutical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
McGrath, L. J., Kim, M., Pritchard, D., Yu, Y., Samai, P., Balasubramanian, A., … Brookhart, M. A. (2021). Using negative control outcomes to assess the comparability of treatment groups among postmenopausal women switching osteoporosis therapy. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (Vol. 30, pp. 389–390).
McGrath, Leah J., Min Kim, David Pritchard, Ying Yu, Peter Samai, Akhila Balasubramanian, Jay Lin, et al. “Using negative control outcomes to assess the comparability of treatment groups among postmenopausal women switching osteoporosis therapy.” In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 30:389–90, 2021.
McGrath LJ, Kim M, Pritchard D, Yu Y, Samai P, Balasubramanian A, et al. Using negative control outcomes to assess the comparability of treatment groups among postmenopausal women switching osteoporosis therapy. In: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2021. p. 389–90.
McGrath, Leah J., et al. “Using negative control outcomes to assess the comparability of treatment groups among postmenopausal women switching osteoporosis therapy.” PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, vol. 30, 2021, pp. 389–90.
McGrath LJ, Kim M, Pritchard D, Yu Y, Samai P, Balasubramanian A, Lin J, Spangler L, Stad R, Bradbury BD, Brookhart MA. Using negative control outcomes to assess the comparability of treatment groups among postmenopausal women switching osteoporosis therapy. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2021. p. 389–390.
Published In
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
EISSN
1099-1557
ISSN
1053-8569
Publication Date
2021
Volume
30
Start / End Page
389 / 390
Related Subject Headings
- Pharmacology & Pharmacy
- 4202 Epidemiology
- 3214 Pharmacology and pharmaceutical sciences
- 1117 Public Health and Health Services
- 1115 Pharmacology and Pharmaceutical Sciences